Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Converging pathways of chromogranin and amyloid metabolism in the brain.
Mattsson N, Johansson P, Hansson O, Wallin A, Johansson JO, Andreasson U, Andersen O, Haghighi S, Olsson M, Stridsberg M, Svensson J, Blennow K, Zetterberg H. Mattsson N, et al. Among authors: johansson p, johansson jo. J Alzheimers Dis. 2010;20(4):1039-49. doi: 10.3233/JAD-2010-091651. J Alzheimers Dis. 2010. PMID: 20413871
Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.
Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Månsson JE, Johansson JO, Olsson B, Wallin A, Svensson J, Blennow K, Zetterberg H. Mattsson N, et al. Among authors: johansson p, johansson jo. Neuromolecular Med. 2011 Jun;13(2):151-9. doi: 10.1007/s12017-011-8147-9. Epub 2011 May 13. Neuromolecular Med. 2011. PMID: 21567187
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.
Movérare-Skrtic S, Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Zetterberg H, Blennow K, Svensson J. Movérare-Skrtic S, et al. Among authors: johansson p, johansson jo. Exp Gerontol. 2012 Feb;47(2):179-82. doi: 10.1016/j.exger.2011.12.005. Epub 2011 Dec 22. Exp Gerontol. 2012. PMID: 22210159
The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms.
O'Dowd ST, Ardah MT, Johansson P, Lomakin A, Benedek GB, Roberts KA, Cummins G, El Agnaf OM, Svensson J, Zetterberg H, Lynch T, Walsh DM. O'Dowd ST, et al. Among authors: johansson p. J Alzheimers Dis. 2013;33(4):923-8. doi: 10.3233/JAD-2012-121393. J Alzheimers Dis. 2013. PMID: 23034520
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease.
Johansson P, Almqvist EG, Johansson JO, Mattsson N, Hansson O, Wallin A, Blennow K, Zetterberg H, Svensson J. Johansson P, et al. Among authors: johansson jo. Psychoneuroendocrinology. 2013 Jul;38(7):1058-66. doi: 10.1016/j.psyneuen.2012.10.012. Epub 2012 Nov 14. Psychoneuroendocrinology. 2013. PMID: 23159010
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
Johansson P, Åberg D, Johansson JO, Mattsson N, Hansson O, Ahrén B, Isgaard J, Åberg ND, Blennow K, Zetterberg H, Wallin A, Svensson J. Johansson P, et al. Among authors: johansson jo. Psychoneuroendocrinology. 2013 Sep;38(9):1729-37. doi: 10.1016/j.psyneuen.2013.02.006. Epub 2013 Mar 6. Psychoneuroendocrinology. 2013. PMID: 23473966
1,618 results